EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Diabetes: a tipping point in neurodegenerative diseases

Jose A Santiago, Mridula Karthikeyan, Madison Lackey, Diana Villavicencio, Judith A Potashkin

Trends in Molecular Medicine · 2023-12 · 29 (12) · 1029-1044

DOI: 10.1016/j.molmed.2023.09.005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Molecular Medicine, 2023-12. Verfasst von Jose A Santiago und 4 weiteren Autor:innen. Beteiligte Einrichtung: NeuroHub Analytics, LLC, Chicago, IL, USA. Electronic address: jose.santiago@neurohubanalytics.com. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis, Diabetes Mellitus. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, Rosalind Franklin University of Medicine and Science, Cure Parkinson's Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes is associated with an increased risk and progression of Alzheimer's (AD) and Parkinson's (PD) diseases. Conversely, diabetes may confer neuroprotection against amyotrophic lateral sclerosis (ALS). It has been posited that perturbations in glucose and insulin regulation, cholesterol metabolism, and mitochondrial bioenergetics defects may underlie the molecular underpinnings of diabetes effects on the brain. Nevertheless, the precise molecular mechanisms remain elusive. Here, we discuss the evidence from molecular, epidemiological, and clinical studies investigating the impact of diabetes on neurodegeneration and highlight shared dysregulated pathways between these complex comorbidities. We also discuss promising antidiabetic drugs, molecular diagnostics currently in clinical trials, and outstanding questions and challenges for future pursuit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesAmyotrophic Lateral SclerosisDiabetes MellitusHumansMitochondriaBrain

Stichwörter der Autor:innen

Alzheimer’s diseaseParkinson’s diseaseamyotrophic lateral sclerosisdiabetesinsulin resistance

Autor:innen und Institutionen

  • NeuroHub Analytics, LLC, Chicago, IL, USA. Electronic address: jose.santiago@neurohubanalytics.com.
  • NeuroHub Analytics, LLC, Chicago, IL, USA.
  • Center for Neurodegenerative Diseases and Therapeutics, Cellular and Molecular Pharmacology Department, The Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA. Electroni…

Förderung

  • NIA NIH HHS
  • Rosalind Franklin University of Medicine and Science
  • Cure Parkinson's Trust
  • National Institute on Aging

Zitieren

APA

Santiago, J. A., Karthikeyan, M., Lackey, M., Villavicencio, D., & Potashkin, J. A. (2023). Diabetes: a tipping point in neurodegenerative diseases. Trends in Molecular Medicine, 29(12), 1029-1044. https://doi.org/10.1016/j.molmed.2023.09.005

Vancouver

Santiago JA, Karthikeyan M, Lackey M, Villavicencio D, Potashkin JA. Diabetes: a tipping point in neurodegenerative diseases. Trends in Molecular Medicine. 2023;29(12):1029-1044. doi:10.1016/j.molmed.2023.09.005

BibTeX
@article{Santiago2023,
  author = {Santiago, Jose A and Karthikeyan, Mridula and Lackey, Madison and Villavicencio, Diana and Potashkin, Judith A},
  title = {Diabetes: a tipping point in neurodegenerative diseases},
  journal = {Trends in Molecular Medicine},
  year = {2023},
  volume = {29},
  number = {12},
  pages = {1029--1044},
  doi = {10.1016/j.molmed.2023.09.005}
}
Kostenlos starten →